https://www.selleckchem.com/pr....oducts/epalrestat.ht
MRD levels were between 0.001% and less then 0.01% on day 19 in 29 patients. These patients had a 5-year CIR that was significantly higher than that of patients with undetectable residual leukemia (17.2% ± 7.2% vs 5.3% ± 1.7%, respectively; P = .02). Our study shows that children with VLR ALL can be treated successfully with decreased-intensity therapy, and it suggests that the classification criteria for VLR can be further refined by using a more sensitive MRD assay.Thrombin generation is pivotal to both physiological blood clot for
Like
Comment
Share
